The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-03
DOI
10.3389/fnins.2018.00520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology
- (2018) Patricia Alonso-Andrés et al. BRAIN PATHOLOGY
- Neurotrophic Factors in Parkinson’s Disease: What have we Learned from Pre-Clinical and Clinical Studies?
- (2018) Rodrigo Novaes Ferreira et al. CURRENT MEDICINAL CHEMISTRY
- Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease
- (2018) Chia-Chia Lee et al. MOLECULAR NEUROBIOLOGY
- Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors
- (2018) Mariana Temido-Ferreira et al. MOLECULAR PSYCHIATRY
- Istradefylline reduces memory deficits in aging mice with amyloid pathology
- (2018) Anna G. Orr et al. NEUROBIOLOGY OF DISEASE
- Blockade of adenosine A 2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
- (2018) António C. Silva et al. NEUROBIOLOGY OF DISEASE
- Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
- (2018) Astrid Nehlig PHARMACOLOGICAL REVIEWS
- Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration
- (2018) Christina Ising et al. Cell Death & Disease
- Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
- (2018) Emilie Faivre et al. Frontiers in Molecular Neuroscience
- Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer’s Disease and Affects Mice with Normal Aging
- (2018) Raquel Baeta-Corral et al. Frontiers in Pharmacology
- Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex
- (2018) Amber Kerkhofs et al. Frontiers in Pharmacology
- Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
- (2018) Cyril Laurent et al. Biomedical Journal
- Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates
- (2018) Rebecca P. Gelber et al. JOURNAL OF ALZHEIMERS DISEASE
- Astrocytic Adenosine A2A Receptors Control the Amyloid-β Peptide-Induced Decrease of Glutamate Uptake
- (2018) Marco Matos et al. JOURNAL OF ALZHEIMERS DISEASE
- Case series of mild behavioral impairment: toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition
- (2017) Alicja Cieslak et al. INTERNATIONAL PSYCHOGERIATRICS
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation
- (2017) Talal Jamil Qazi et al. MOLECULAR NEUROBIOLOGY
- Glial contributions to neurodegeneration in tauopathies
- (2017) Cheryl E. G. Leyns et al. Molecular Neurodegeneration
- Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
- (2017) Anastasia G. Efthymiou et al. Molecular Neurodegeneration
- Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease
- (2017) Emrin Horgusluoglu-Moloch et al. NEUROBIOLOGY OF AGING
- Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
- (2017) Gary W. Arendash et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Intake and Dementia: Systematic Review and Meta-Analysis
- (2017) Catarina Santos et al. JOURNAL OF ALZHEIMERS DISEASE
- How does adenosine control neuronal dysfunction and neurodegeneration?
- (2016) Rodrigo A. Cunha JOURNAL OF NEUROCHEMISTRY
- Current and experimental treatments of Parkinson disease: A guide for neuroscientists
- (2016) Wolfgang Oertel et al. JOURNAL OF NEUROCHEMISTRY
- Action of Caffeine as an Amyloid Inhibitor in the Aggregation of Aβ16–22 Peptides
- (2016) Bhanita Sharma et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Adenosinergic signaling in epilepsy
- (2016) Detlev Boison NEUROPHARMACOLOGY
- Adenosine A1receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280
- (2016) Frank J. A. Dennissen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure–induced transient ischemic injury
- (2016) Maria H. Madeira et al. Translational Research
- Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
- (2016) Pier Andrea Borea et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Early synaptic deficits in the APP/PS1 mouse model of Alzheimer’s disease involve neuronal adenosine A2A receptors
- (2016) Silvia Viana da Silva et al. Nature Communications
- An Anti-Parkinson’s Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity
- (2016) Jing Lu et al. PLoS One
- The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function
- (2016) Vânia L. Batalha et al. Scientific Reports
- 2′,3′-cAMP, 3′-AMP, 2′-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors
- (2015) Elizabeth A. Newell et al. BRAIN RESEARCH
- Adenosine A2Areceptors are necessary and sufficient to trigger memory impairment in adult mice
- (2015) N Pagnussat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism
- (2015) Jimmy George et al. GLIA
- Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
- (2015) C Laurent et al. MOLECULAR PSYCHIATRY
- Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
- (2015) Anna G Orr et al. NATURE NEUROSCIENCE
- Pannexin-1-mediated ATP release from area CA3 drives mGlu5-dependent neuronal oscillations
- (2015) Jan Lopatář et al. NEUROPHARMACOLOGY
- Role of adenosine in oligodendrocyte precursor maturation
- (2015) Elisabetta Coppi et al. Frontiers in Cellular Neuroscience
- Restraint stress increases hemichannel activity in hippocampal glial cells and neurons
- (2015) Juan A. Orellana et al. Frontiers in Cellular Neuroscience
- From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
- (2014) Vanessa Flaten et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Astroglial Connexin43 Hemichannels Tune Basal Excitatory Synaptic Transmission
- (2014) O. Chever et al. JOURNAL OF NEUROSCIENCE
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability
- (2014) Do-Geun Kim et al. MOLECULAR NEUROBIOLOGY
- Post-study caffeine administration enhances memory consolidation in humans
- (2014) Daniel Borota et al. NATURE NEUROSCIENCE
- Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
- (2014) Cyril Laurent et al. NEUROBIOLOGY OF AGING
- Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP
- (2014) André Jerónimo-Santos et al. NEUROPHARMACOLOGY
- Hydrogen Sulfide Inhibits A2A Adenosine Receptor Agonist Induced β-Amyloid Production in SH-SY5Y Neuroblastoma Cells via a cAMP Dependent Pathway
- (2014) Bhushan Vijay Nagpure et al. PLoS One
- ATP Release through Lysosomal Exocytosis from Peripheral Nerves: The Effect of Lysosomal Exocytosis on Peripheral Nerve Degeneration and Regeneration after Nerve Injury
- (2014) Junyang Jung et al. Biomed Research International
- DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease
- (2013) Jose V. Sanchez-Mut et al. BRAIN
- Microglia release ATP by exocytosis
- (2013) Yoshio Imura et al. GLIA
- Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
- (2013) Rebecca L. Williams-Karnesky et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of intracellular ATP determines adenosine release and functional outcome in response to metabolic stress in rat hippocampal slices and cerebellar granule cells
- (2013) Stephanie zur Nedden et al. JOURNAL OF NEUROCHEMISTRY
- Antagonistic Interaction between Adenosine A2A Receptors and Na+/K+-ATPase- 2 Controlling Glutamate Uptake in Astrocytes
- (2013) M. Matos et al. JOURNAL OF NEUROSCIENCE
- Adenosine A2A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures
- (2013) Elisabetta Coppi et al. NEUROPHARMACOLOGY
- A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
- (2013) Sofia Cristóvão-Ferreira et al. Purinergic Signalling
- Regulation of Lymphocyte Function by Adenosine
- (2012) Joel Linden et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Possible ATP release through lysosomal exocytosis from primary sensory neurons
- (2012) Junyang Jung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
- (2012) Marco Matos et al. GLIA
- Adenosine Release during Seizures Attenuates GABAA Receptor-Mediated Depolarization
- (2012) A. Ilie et al. JOURNAL OF NEUROSCIENCE
- Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
- (2012) V L Batalha et al. MOLECULAR PSYCHIATRY
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease
- (2011) Anil Kachroo et al. ANNALS OF NEUROLOGY
- Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
- (2011) Fiona E. Parkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- Neural and humoral control of regional vascular beds via A1 adenosine receptors located in the nucleus tractus solitarii
- (2010) Joseph M. McClure et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet
- (2010) Jaya R.P. Prasanthi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
- (2010) Bart De Strooper PHYSIOLOGICAL REVIEWS
- Adenosine, energy metabolism and sleep homeostasis
- (2010) Tarja Porkka-Heiskanen et al. SLEEP MEDICINE REVIEWS
- Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by -Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
- (2009) P. M. Canas et al. JOURNAL OF NEUROSCIENCE
- RESEARCH ARTICLE: Up-regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease
- (2008) José L. Albasanz et al. BRAIN PATHOLOGY
- Brain metabolism dictates the polarity of astrocyte control over arterioles
- (2008) Grant R. J. Gordon et al. NATURE
- Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber Synapses
- (2008) Nelson Rebola et al. NEURON
- Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801
- (2007) Geanne M.A. Cunha et al. EXPERIMENTAL NEUROLOGY
- Adenosine in the central nervous system: release mechanisms and extracellular concentrations
- (2003) Serena Latini et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now